| Schering-Plough Corporation |
A securities class action has been filed against Schering-Plough and certain of its officers and directors alleging that the Company misrepresented and omitted material facts concerning its drug Vytorin and Setia. When news of the alleged fraud reached the market the companys stock dropped substantially. You may serve as a lead plaintiff and seek to recover damages on behalf of investors in Schering-Plough stock. Please click on the link in the upper right corner to join this litigation as a lead plaintiff. |
| For more Information | |
 Case Summary
|
|
|
Press Release
|
|
 Read the Complaint
|
|
|